We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.01T
AUM Growth
+$82B
Cap. Flow
+$21.4B
Cap. Flow %
2.11%
Top 10 Hldgs %
17.99%
Holding
7,861
New
173
Increased
3,407
Reduced
3,131
Closed
203

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.06B
2
AMZN icon
Amazon
AMZN
+$1.51B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.42B
4
TSLA icon
Tesla
TSLA
+$1.17B
5
MSFT icon
Microsoft
MSFT
+$997M

Sector Composition

Rank Sector Weight
1 Technology 20.98%
2 Healthcare 10.48%
3 Financials 9.86%
4 Consumer Discretionary 8.78%
5 Industrials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
5601
DELISTED
Tourmaline Bio
TRML
$147K ﹤0.01%
4,840
-22,624
-82% -$578K
ARKX icon
5602
ARK Space & Defense Innovation ETF
ARKX
$814M
$147K ﹤0.01%
9,676
+1,363
+16% +$18.9K
BRZU icon
5603
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$104M
$147K ﹤0.01%
1,644
+1,029
+167% +$77K
PSEP icon
5604
Innovator US Equity Power Buffer ETF September
PSEP
$845M
$147K ﹤0.01%
4,492
VIGL
5605
DELISTED
Vigil Neuroscience
VIGL
$147K ﹤0.01%
15,625
-42,719
-73% -$404K
FCAP icon
5606
First Capital
FCAP
$220M
$146K ﹤0.01%
4,741
MRBK icon
5607
Meridian
MRBK
$235M
$146K ﹤0.01%
14,890
-7,502
-34% -$75.9K
ATHE
5608
Alterity Therapeutics
ATHE
$82.3M
$146K ﹤0.01%
52,185
-1,300
-2% -$3.69K
FENG
5609
Phoenix New Media
FENG
$17.5M
$146K ﹤0.01%
73,961
-1,533
-2% -$3.53K
CGGO icon
5610
Capital Group Global Growth Equity ETF
CGGO
$11.5B
$146K ﹤0.01%
5,994
+472
+9% +$11.1K
CTMX icon
5611
CytomX Therapeutics
CTMX
$686M
$145K ﹤0.01%
84,276
-67,099
-44% -$111K
IPHA
5612
Innate Pharma
IPHA
$161M
$145K ﹤0.01%
47,049
-1,673
-3% -$5.14K
ABSI icon
5613
Absci
ABSI
$1.33B
$145K ﹤0.01%
95,149
-22,000
-19% -$35.4K
TBLA icon
5614
Taboola.com
TBLA
$1.4B
$145K ﹤0.01%
46,495
-352,657
-88% -$966K
SGTX
5615
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$144K ﹤0.01%
6,418
-12,569
-66% -$91.2K
BDEC icon
5616
Innovator US Equity Buffer ETF December
BDEC
$220M
$144K ﹤0.01%
3,980
EGAN icon
5617
eGain
EGAN
$192M
$144K ﹤0.01%
19,191
-19,877
-51% -$145K
IMUX icon
5618
Immunic
IMUX
$192M
$143K ﹤0.01%
5,711
-46,737
-89% -$783K
CMLS
5619
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$143K ﹤0.01%
34,909
-1,605,458
-98% -$5.4M
ITEQ icon
5620
Amplify BlueStar Israel Technology ETF
ITEQ
$112M
$143K ﹤0.01%
3,091
+1,156
+60% +$52.5K
DIT icon
5621
AMCON Distributing
DIT
$143K ﹤0.01%
1,056
+6
+0.6% +$767
VOR icon
5622
Vor Biopharma
VOR
$1.16B
$143K ﹤0.01%
2,311
-1,163
-33% -$106K
NTSX icon
5623
WisdomTree US Efficient Core Fund
NTSX
$1.37B
$142K ﹤0.01%
3,837
CIK
5624
Credit Suisse Asset Management Income Fund
CIK
$134M
$141K ﹤0.01%
48,107
-11,905
-20% -$32.9K
TESS
5625
DELISTED
Tessco Technologies Inc
TESS
$141K ﹤0.01%
15,793
-12,452
-44% -$105K

Similar funds

Morgan Stanley's Q2 2023 Portfolio in Review

As of Q2 2023, Morgan Stanley held 7,861 positions worth $1.01T, up 8.8% from $933B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.8%. Morgan Stanley opened 173 new positions and exited 203, leaving the 7,861-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 3,490,516 shares worth $87.1M.
  • Morgan Stanley added most to NVIDIA in Q2 2023, an estimated $2.06B increase.
  • Morgan Stanley's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $724M.
  • Morgan Stanley fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $925M.
  • Morgan Stanley's ten largest holdings make up 18% of its $1.01T portfolio in Q2 2023.
  • Morgan Stanley opened 173 new positions and closed 203 in Q2 2023.
  • Morgan Stanley's portfolio value rose 8.8% quarter-over-quarter to $1.01T.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.